Literature DB >> 21333842

Prevention of the first episode of psychosis.

William R McFarlane1.   

Abstract

Long a desired goal but increasingly a focus of research on clinical practice, prevention of psychosis has emerged as one of the most promising and effective areas of investigational interest and effort in psychiatry. Spurred by long-term studies that have associated outcome with duration of untreated psychosis, current research is focused on improving the accuracy of prediction based on clinical and neurocognitive measures and on refining treatments of the earliest symptoms of the psychoses. Both efforts are bearing success, although there remains ambiguity as to the most effective preventive interventions. This article reviews the leading studies of, and remaining issues for, this important enterprise.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21333842      PMCID: PMC3073532          DOI: 10.1016/j.psc.2010.11.012

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  35 in total

1.  Duration of untreated psychosis and cognitive functioning in first-episode patients.

Authors:  R M Norman; L Townsend; A K Malla
Journal:  Br J Psychiatry       Date:  2001-10       Impact factor: 9.319

2.  Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-admitted patients.

Authors:  H Verdoux; F Liraud; C Bergey; F Assens; F Abalan; J van Os
Journal:  Schizophr Res       Date:  2001-04-30       Impact factor: 4.939

3.  Treatment of patients with first-episode psychosis: two-year outcome data from the Danish National Schizophrenia Project.

Authors:  Bent Rosenbaum; Kristian Valbak; Susanne Harder; Per Knudsen; Anne Køster; Matilde Lajer; Anne Lindhardt; Gerda Winther; Lone Petersen; Per Jørgensen; Merete Nordentoft; Anne Helms Andreasen
Journal:  World Psychiatry       Date:  2006-06       Impact factor: 49.548

Review 4.  Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis.

Authors:  Diana O Perkins; Hongbin Gu; Kalina Boteva; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

5.  Diagnosing schizophrenia in the initial prodromal phase.

Authors:  J Klosterkötter; M Hellmich; E M Steinmeyer; F Schultze-Lutter
Journal:  Arch Gen Psychiatry       Date:  2001-02

6.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Authors:  G Paul Amminger; Miriam R Schäfer; Konstantinos Papageorgiou; Claudia M Klier; Sue M Cotton; Susan M Harrigan; Andrew Mackinnon; Patrick D McGorry; Gregor E Berger
Journal:  Arch Gen Psychiatry       Date:  2010-02

Review 7.  The costs of schizophrenia. Assessing the burden.

Authors:  A Rupp; S J Keith
Journal:  Psychiatr Clin North Am       Date:  1993-06

Review 8.  The predictive utility of expressed emotion in schizophrenia: an aggregate analysis.

Authors:  P Bebbington; L Kuipers
Journal:  Psychol Med       Date:  1994-08       Impact factor: 7.723

9.  Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals.

Authors:  Daqiang Sun; Lisa Phillips; Dennis Velakoulis; Alison Yung; Patrick D McGorry; Stephen J Wood; Theo G M van Erp; Paul M Thompson; Arthur W Toga; Tyrone D Cannon; Christos Pantelis
Journal:  Schizophr Res       Date:  2009-01-12       Impact factor: 4.939

10.  Genotype-environment interaction in schizophrenia-spectrum disorder. Long-term follow-up study of Finnish adoptees.

Authors:  Pekka Tienari; Lyman C Wynne; Anneli Sorri; Ilpo Lahti; Kristian Läksy; Juha Moring; Mikko Naarala; Pentti Nieminen; Karl-Erik Wahlberg
Journal:  Br J Psychiatry       Date:  2004-03       Impact factor: 9.319

View more
  8 in total

Review 1.  The development of psychotic disorders in adolescence: a potential role for hormones.

Authors:  Hanan D Trotman; Carrie W Holtzman; Arthur T Ryan; Daniel I Shapiro; Allison N MacDonald; Sandra M Goulding; Joy L Brasfield; Elaine F Walker
Journal:  Horm Behav       Date:  2013-07       Impact factor: 3.587

Review 2.  Stress and neurodevelopmental processes in the emergence of psychosis.

Authors:  C W Holtzman; H D Trotman; S M Goulding; A T Ryan; A N Macdonald; D I Shapiro; J L Brasfield; E F Walker
Journal:  Neuroscience       Date:  2013-01-05       Impact factor: 3.590

3.  Factor analysis of the Scale of Prodromal Symptoms: data from the Early Detection and Intervention for the Prevention of Psychosis Program.

Authors:  Ivy F Tso; Stephan F Taylor; Tyler B Grove; Tara Niendam; Steven Adelsheim; Andrea Auther; Barbara Cornblatt; Cameron S Carter; Roderick Calkins; J Daniel Ragland; Tamara Sale; William R McFarlane
Journal:  Early Interv Psychiatry       Date:  2014-12-21       Impact factor: 2.732

4.  Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention.

Authors:  Neeraj Tandon; Jai Shah; Matcheri S Keshavan; Rajiv Tandon
Journal:  Neuropsychiatry (London)       Date:  2012

5.  Cognitive Brain Signatures of Youth With Early Onset and Relatives With Schizophrenia: Evidence From fMRI Meta-analyses.

Authors:  Marie Arsalidou; Zachary Yaple; Tomas Jurcik; Vadim Ushakov
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

Review 6.  What can triumphs and tribulations from drug research in Alzheimer's disease tell us about the development of psychotropic drugs in general?

Authors:  Robert E Becker; Mary V Seeman; Nigel H Greig; Debomoy K Lahiri
Journal:  Lancet Psychiatry       Date:  2015-08       Impact factor: 27.083

Review 7.  First-episode psychosis: How long does it last? A review of evolution and trajectory.

Authors:  Jyoti Prakash; K Chatterjee; K Srivastava; V S Chauhan
Journal:  Ind Psychiatry J       Date:  2021-07-20

8.  Smartphone Apps to Support Coordinated Specialty Care for Prodromal and Early Course Schizophrenia Disorders: Systematic Review.

Authors:  Erica Camacho; Leonard Levin; John Torous
Journal:  J Med Internet Res       Date:  2019-11-12       Impact factor: 5.428

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.